689 related articles for article (PubMed ID: 10528604)
1. Low-dose vasopressin in the treatment of vasodilatory septic shock.
Malay MB; Ashton RC; Landry DW; Townsend RN
J Trauma; 1999 Oct; 47(4):699-703; discussion 703-5. PubMed ID: 10528604
[TBL] [Abstract][Full Text] [Related]
2. Fixed-dose vasopressin compared with titrated dopamine and norepinephrine as initial vasopressor therapy for septic shock.
Hall LG; Oyen LJ; Taner CB; Cullinane DC; Baird TK; Cha SS; Sawyer MD
Pharmacotherapy; 2004 Aug; 24(8):1002-12. PubMed ID: 15338849
[TBL] [Abstract][Full Text] [Related]
3. Beneficial effects of short-term vasopressin infusion during severe septic shock.
Patel BM; Chittock DR; Russell JA; Walley KR
Anesthesiology; 2002 Mar; 96(3):576-82. PubMed ID: 11873030
[TBL] [Abstract][Full Text] [Related]
4. Hemodynamic effects of i.v. milrinone lactate in pediatric patients with septic shock. A prospective, double-blinded, randomized, placebo-controlled, interventional study.
Barton P; Garcia J; Kouatli A; Kitchen L; Zorka A; Lindsay C; Lawless S; Giroir B
Chest; 1996 May; 109(5):1302-12. PubMed ID: 8625683
[TBL] [Abstract][Full Text] [Related]
5. Hemodynamic and metabolic effects of low-dose vasopressin infusions in vasodilatory septic shock.
Tsuneyoshi I; Yamada H; Kakihana Y; Nakamura M; Nakano Y; Boyle WA
Crit Care Med; 2001 Mar; 29(3):487-93. PubMed ID: 11373409
[TBL] [Abstract][Full Text] [Related]
6. Vasopressin versus norepinephrine infusion in patients with septic shock.
Russell JA; Walley KR; Singer J; Gordon AC; Hébert PC; Cooper DJ; Holmes CL; Mehta S; Granton JT; Storms MM; Cook DJ; Presneill JJ; Ayers D;
N Engl J Med; 2008 Feb; 358(9):877-87. PubMed ID: 18305265
[TBL] [Abstract][Full Text] [Related]
7. Cardiovascular effects of the nitric oxide synthase inhibitor NG-methyl-L-arginine hydrochloride (546C88) in patients with septic shock: results of a randomized, double-blind, placebo-controlled multicenter study (study no. 144-002).
Watson D; Grover R; Anzueto A; Lorente J; Smithies M; Bellomo R; Guntupalli K; Grossman S; Donaldson J; Le Gall JR;
Crit Care Med; 2004 Jan; 32(1):13-20. PubMed ID: 14707555
[TBL] [Abstract][Full Text] [Related]
8. The effect of vasopressin on gastric perfusion in catecholamine-dependent patients in septic shock.
van Haren FM; Rozendaal FW; van der Hoeven JG
Chest; 2003 Dec; 124(6):2256-60. PubMed ID: 14665508
[TBL] [Abstract][Full Text] [Related]
9. Effects of continuous vasopressin infusion in patients with septic shock.
Obritsch MD; Jung R; Fish DN; MacLaren R
Ann Pharmacother; 2004; 38(7-8):1117-22. PubMed ID: 15178740
[TBL] [Abstract][Full Text] [Related]
10. Early prediction of norepinephrine dependency and refractory septic shock with a multimodal approach of vascular failure.
Conrad M; Perez P; Thivilier C; Levy B
J Crit Care; 2015 Aug; 30(4):739-43. PubMed ID: 25900257
[TBL] [Abstract][Full Text] [Related]
11. Vasopressin deficiency contributes to the vasodilation of septic shock.
Landry DW; Levin HR; Gallant EM; Ashton RC; Seo S; D'Alessandro D; Oz MC; Oliver JA
Circulation; 1997 Mar; 95(5):1122-5. PubMed ID: 9054839
[TBL] [Abstract][Full Text] [Related]
12. Does body weight impact the efficacy of vasopressin therapy in the management of septic shock?
Miller JT; Welage LS; Kraft MD; Alaniz C
J Crit Care; 2012 Jun; 27(3):289-93. PubMed ID: 21855282
[TBL] [Abstract][Full Text] [Related]
13. The cardiopulmonary effects of vasopressin compared with norepinephrine in septic shock.
Gordon AC; Wang N; Walley KR; Ashby D; Russell JA
Chest; 2012 Sep; 142(3):593-605. PubMed ID: 22518026
[TBL] [Abstract][Full Text] [Related]
14. Changes in vasopressin use and outcomes in surgical intensive care unit patients with septic shock.
Lupei MI; Beilman GJ; Chipman JG; Mann HJ
Chirurgia (Bucur); 2009; 104(5):575-81. PubMed ID: 19943557
[TBL] [Abstract][Full Text] [Related]
15. Stress doses of hydrocortisone reverse hyperdynamic septic shock: a prospective, randomized, double-blind, single-center study.
Briegel J; Forst H; Haller M; Schelling G; Kilger E; Kuprat G; Hemmer B; Hummel T; Lenhart A; Heyduck M; Stoll C; Peter K
Crit Care Med; 1999 Apr; 27(4):723-32. PubMed ID: 10321661
[TBL] [Abstract][Full Text] [Related]
16. Selepressin, a novel selective vasopressin V
Russell JA; Vincent JL; Kjølbye AL; Olsson H; Blemings A; Spapen H; Carl P; Laterre PF; Grundemar L
Crit Care; 2017 Aug; 21(1):213. PubMed ID: 28807037
[TBL] [Abstract][Full Text] [Related]
17. Effects of norepinephrine plus dobutamine or norepinephrine alone on left ventricular performance of septic shock patients.
Martin C; Viviand X; Arnaud S; Vialet R; Rougnon T
Crit Care Med; 1999 Sep; 27(9):1708-13. PubMed ID: 10507587
[TBL] [Abstract][Full Text] [Related]
18. Evaluating Vasopressor Discontinuation Strategies in Patients With Septic Shock on Concomitant Norepinephrine and Vasopressin Infusions.
Musallam N; Altshuler D; Merchan C; Zakhary B; Aberle C; Papadopoulos J
Ann Pharmacother; 2018 Aug; 52(8):733-739. PubMed ID: 29560736
[TBL] [Abstract][Full Text] [Related]
19. Role of vasopressin in the management of septic shock.
Mutlu GM; Factor P
Intensive Care Med; 2004 Jul; 30(7):1276-91. PubMed ID: 15103461
[TBL] [Abstract][Full Text] [Related]
20. Continuous terlipressin versus vasopressin infusion in septic shock (TERLIVAP): a randomized, controlled pilot study.
Morelli A; Ertmer C; Rehberg S; Lange M; Orecchioni A; Cecchini V; Bachetoni A; D'Alessandro M; Van Aken H; Pietropaoli P; Westphal M
Crit Care; 2009; 13(4):R130. PubMed ID: 19664253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]